Subscribe to RSS
DOI: 10.1055/s-0042-115173
Application of a silver coating on plastic biliary stents to prevent biofilm formation: an experimental study using electron microscopy
Publication History
submitted21 March 2016
accepted after revision29 July 2016
Publication Date:
14 September 2016 (online)
Background and study aims: Biliary stent dysfunction is mainly caused by biliary sludge that forms as a result of bacterial adherence and subsequent biofilm formation on the inner surface of the stent. Silver ions arewell known to have excellent antimicrobial activity against a wide range of microorganisms. In this study, we designed and constructed silver-coated plastic stent (PS) and investigated whether the silver coating prevented bacterial adherence and biofilm formation through the use of electron microscopy.
Material and methods: The polyurethane PS with/without silver coating were prepared in 6-inch segments. The silver-based antimicrobial agents were electrostatically applied onto the stent surface. The stents were then immersed for 5 weeks in infected human bile juice obtained from a patient with cholangitis, and electron microscopy was used to investigate the ability of the modified PS to prevent bacterial adherence and biofilm formation.
Results: The bacterial flora did not change before and after immersion of stents in both the group with and without silver coating. Electron microscopic observation revealed meshwork-like structures around the bacteria, characteristic of biofilm-forming bacteria, in all stents from the control group (6/6, 100 %). On the other hand, a limited number of bacteria were observed in all stents in the silver-coated group, and no apparent biofilm formation was observed (0/6, 0 %).
Conclusions: The significance of the findings from our study is the ability of silver-coated PS to prevent biofilm formation on the stent surface, which results in the prevention of stent occlusion.
-
References
- 1 Mukai T, Yasuda I, Nakashima M et al. Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial. J Hepatobiliary Pancreat Sci 2013; 20: 214-222
- 2 Isayama H, Yasuda I, Ryozawa S et al. Results of a Japanese multicenter, randomized trial of endoscopic stenting for non-resectable pancreatic head cancer (JM-test): Covered Wallstent versus DoubleLayer stent. Dig Endosc 2011; 23: 310-315
- 3 Bernon M, Shaw J, Krige J et al. Malignant biliary obstruction: A prospective randomised trial comparing plastic and metal stents for palliation of symptomatic jaundice. HPB 2011; 13: 139-145
- 4 Soderlund C, Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc 2006; 63: 986-995
- 5 Leung JW, Ling TK, Kung JL et al. The role of bacteria in the blockage of biliary stents. Gastrointest Endosc 1988; 34: 19-22
- 6 Speer AG, Cotton PB, Rode J et al. Biliary stent blockage with bacterial biofilm. Ann Intern Med 1988; 108: 546-553
- 7 Sung JY, Leung JW, Shaffer EA et al. Ascending infection of the biliary tract after surgical sphincterotomy and biliary stenting. J Gastroenterol Hepatol 1992; 7: 240-245
- 8 Pederson FM, Lassen AT, de Muckadell OBS. Randomized trial of stent placed above and across the sphincter of Oddi in malignant bile duct obstruction. Gastrointest Endosc 1998; 48: 574-579
- 9 Liau SY, Read DC, Pugh WJ et al. Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions. Lett Appl Microbiol 1997; 25: 279-283
- 10 Seo Y, Hwang J, Kim J et al. Antibacterial activity and cytotoxicity of multi-walled carbon nanotubes decorated with silver nanoparticles. Int J Nanomedicine 2014; 9: 4621-4629
- 11 Neelgund GM, Oki A. Deposition of silver nanoparticles on dendrimer functionalized multiwalled carbon nanotubes: synthesis, characterization and antimicrobial activity. J Nanosci Nanotechnol 2011; 11: 3621-3629
- 12 Flores CY, Minan AG, Grillo CA et al. Citrate-capped silver nanoparticles showing good bactericidal effect against both planktonic and sessile bacteria and a low cytotoxicity to osteoblastic cells. ACS Appl Mater Interfaces 2013; 5: 3149-3159
- 13 Kim JS, Kuk E, Yu KN et al. Antimicrobial effects of silver nanoparticles. Nanomedicine 2007; 3: 95-101
- 14 Leung JW, Lau GT, Sung JJ et al. Decreased bacterial adherence to silver-coated stent material: an in vitro study. Gastrointest Endosc 1992; 38: 338-340
- 15 van Berkel AM, Boland C, Redekop WK et al. A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction. Endoscopy 1998; 30: 681-686
- 16 Davids PH, Groen AK, Rauws EA et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992; 340: 1488-1492
- 17 Dumonceau JM, Tringali A, Blero D et al. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy 2012; 44: 277-298
- 18 Dowidar N, Kolmos HJ, Lyon H et al. Clogging of biliary endoprostheses. A morphologic and bacteriologic study. Scand J Gastroentero 1991; 26: 1137-1144
- 19 McAllister EW, Carey LC, Brady PG et al. The role of polymeric surface smoothness of biliary stents in bacterial adherence, biofilm deposition, and stent occlusion. Gastrointest Endosc 1993; 39: 422-425
- 20 Weickert U, Venzke T, Konig J et al. Why do bilioduodenal plastic stents become occluded? A clinical and pathological investigation on 100 consecutive patients. Endoscopy 2001; 33: 786-790
- 21 Dowidar N, Kolmos HJ, Matzen P. Experimental clogging of biliary endoprostheses. Role of bacteria, endoprosthesis material, and design. Scand J Gastroenterol 1992; 27: 77-80
- 22 Ahmad SAI, Bari SMN, Mohiuddin M. Biofilm: multicellular living of the unicellular bacteria. International Journal of Biosciences 2012; 2: 59-71
- 23 Costerton JW, Cheng KJ, Geesey GG et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol 1987; 41: 435-464
- 24 Costerton JW, Lewandowski Z, DeBeer D et al. Biofilms, the customized microniche. J Bacteriol 1994; 176: 2137-2142
- 25 Davey ME, O'Toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 2000; 64: 847-867
- 26 Watnick P, Kolter R. Biofilm, city of microbes. J Bacteriol 2000; 182: 2675-2679
- 27 Kumar R, Munstedt H. Silver ion release from antimicrobial polyamide/silver composites. Biomaterials 2005; 26: 2081-2088
- 28 Lee D, Cohen RE, Rubner MF. Antibacterial properties of Ag nanoparticle loaded multilayers and formation of magnetically directed antibacterial microparticles. Langmuir 2005; 21: 9651-9659
- 29 Schierholz JM, Lucas LJ, Rump A et al. Efficacy of silver‐coated medical devices. J Hosp Infect 1998; 40: 257-262
- 30 Morones JR, Elechiguerra JL, Camacho A et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005; 16: 2346-2353
- 31 Russell AD, Hugo WB. Antimicrobial activity and action of silver. Prog Med Chem 1994; 31: 351-370
- 32 Carsin H, Wassermann D, Pannier M et al. A silver sulphadiazine-impregnated lipidocolloid wound dressing to treat second-degree burns. J Wound Care 2004; 13: 145-148
- 33 Wright JB, Lam K, Hansen D et al. Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999; 27: 344-350
- 34 Kumon H. Pathogenesis and management of bacterial biofilms in the urinary tract. J Infect Chemother 1996; 2: 18-28
- 35 Wen W, Ma LM, He W et al. Silver-nanoparticle-coated biliary stent inhibits bacterial adhesion in bacterial cholangitis in swine. Hepatobiliary Pancreat Dis Int 2016; 15: 87-92